· Earnings watch · TLX

Telix Pharmaceuticals Limited (TLX) approaches earnings with momentum split

The radiopharmaceuticals developer reports on June 18 with a recent weekly gain set against a weaker four-week tape.

Biotechnology market data screen and radiopharmaceutical lab equipment representing Telix Pharmaceuticals before earnings.

Telix Pharmaceuticals Limited (TLX) closed at 9.560 USD in the latest weekly market data ahead of its June 18 earnings date, with the stock up 2.8% for the week but down 9.5% over four weeks.

The setup is mixed. The trend signal remains active and twelve-week performance is positive at 9.3%, while Relative Strength is negative at -21.3 and Market Dynamics at 0.44 offers only limited confirmation. Volume was modestly above the 13-week average at 1.09x.

The chart is weekly price path over 52 weeks, so it frames broader positioning rather than live intraday trading. The earnings calendar shows a fiscal-quarter estimate of -0.01 USD for the period ending March 31.

TLX coverage